|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
GlaxoSmithKline's new chief executive announced plans on Wednesday to narrow the focus of the group's drug research by ditching more than 30 drug projects to improve returns in its core pharmaceuticals ...
Novartis AG (ADR) (NYSE: NVS ) has been all over the news lately as its cancer drug moves closer to FDA approval, and Morgan Stanley analyst Vincent Meunier believes the recent news flow suggests a less ...